Yueh‐Min Lin

Changhua Christian Hospital — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.1kcitations123works3.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(29), Cancer-related gene regulation(18), Cell death mechanisms and regulation(6), Cell Adhesion Molecules Research(6), Mesenchymal stem cell research(5)

Publications123 total

Corrigendum to “Inducible gankyrin overexpression drives hepatocarcinogenesis in a liver-specific zebrafish model” [Acta Histochem. 127 (2025) 152280]
Acta Histochemica·2025
Inducible gankyrin overexpression drives hepatocarcinogenesis in a liver-specific zebrafish model
Acta Histochemica·2025· 1 citedOpen Access
P55 Federated learning-based artificial intelligence model to predict recurrence free survival in patients with early-stage urothelial carcinoma on BCG-therapy
European Urology Open Science·2025Open Access
A Novel Therapeutic Strategy for Ameliorating Hyperglycemia‐Induced Liver Injury via Overexpression of the Carboxyl Terminus of HSP70‐Interacting Protein in Wharton's Jelly Mesenchymal Stem Cells
Biotechnology and Applied Biochemistry·2025· 3 cited
<i>Rhodiola</i> and Salidroside Attenuate Oxidative Stress‐Triggered H9c2 Cardiomyoblast Apoptosis Through <scp>IGF1R</scp> ‐Induced <scp>ERK1</scp> /2 Activation
Environmental Toxicology·2024· 9 cited
<i>Platycodi radix</i> aqueous extract salvages doxorubicin‐induced senescence by mitochondrial reactive oxygen species reduction in umbilical cord matrix stem cells
Environmental Toxicology·2024· 5 cited
Diallyl trisulfide (DATS) protects cardiac cells against advanced glycation end-product-induced apoptosis by enhancing FoxO3A-dependent upregulation of miRNA-210
The Journal of Nutritional Biochemistry·2024· 8 cited
Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
Journal of Functional Foods·2023Open Access
Gemcitabine resistance in non‐small cell lung cancer is mediated through activation of the PI3K/AKT/NF‐κB pathway and suppression of ERK signaling by reactive oxygen species
Journal of Biochemical and Molecular Toxicology·2023· 12 citedOpen Access
<scp> <i>Ohwia caudata</i> </scp> aqueous extract attenuates doxorubicin‐induced mitochondrial dysfunction in <scp>Wharton</scp> 's jelly‐derived mesenchymal stem cells
Environmental Toxicology·2023· 13 citedOpen Access
Phosphorylation of Bcl‐2 by <scp>JNK</scp> confers gemcitabine resistance in lung cancer cells by reducing autophagy‐mediated cell death
Environmental Toxicology·2023· 8 cited
Fisetin attenuates doxorubicin‐induced cardiotoxicity by inhibiting the insulin‐like growth factor <scp>II</scp> receptor apoptotic pathway through estrogen receptor‐α/‐β activation
Phytotherapy Research·2023· 17 citedOpen Access
Supplemental Table S1 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure S8 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure S2 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure S2 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure Legends from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure S4 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Table S2 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
Supplemental Figure S3 from H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Chih‐Yang Huang(28), Wei‐Wen Kuo(16), Kun‐Tu Yeh(11), Chia‐Hua Kuo(10), Hsi‐Hsien Hsu(8), Ming‐Cheng Chen(8), Jeng‐Wei Lu(8), Vijaya Padma Viswanadha(8), Tsung‐Jung Ho(8), Ray‐Jade Chen(7), Cecilia Hsuan Day(6), Marthandam Asokan Shibu(6), Chih‐Jung Chen(5), Chia‐Yao Shen(5), Chuan‐Chou Tu(4), Wen‐Wei Sung(4), Bharath Kumar Velmurugan(4), Cecilia‐Hsuan Day(4), Shun‐Fa Yang(4), Rathinasamy Baskaran(3)